CW Advisors LLC bought a new position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 15,811 shares of the real estate investment trust's stock, valued at approximately $320,000.
Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. TCTC Holdings LLC lifted its position in Healthpeak Properties by 124.3% during the 1st quarter. TCTC Holdings LLC now owns 1,355 shares of the real estate investment trust's stock valued at $27,000 after purchasing an additional 751 shares during the period. Brooklyn Investment Group grew its stake in shares of Healthpeak Properties by 198.9% in the first quarter. Brooklyn Investment Group now owns 1,312 shares of the real estate investment trust's stock valued at $27,000 after buying an additional 873 shares in the last quarter. Future Financial Wealth Managment LLC bought a new position in Healthpeak Properties during the first quarter worth $30,000. S.A. Mason LLC lifted its holdings in shares of Healthpeak Properties by 160.9% during the first quarter. S.A. Mason LLC now owns 1,500 shares of the real estate investment trust's stock worth $30,000 after buying an additional 925 shares in the last quarter. Finally, Dagco Inc. acquired a new stake in shares of Healthpeak Properties during the first quarter worth $30,000. Institutional investors and hedge funds own 93.57% of the company's stock.
Healthpeak Properties Stock Performance
NYSE DOC traded down $0.07 during midday trading on Tuesday, hitting $17.87. The company had a trading volume of 2,730,634 shares, compared to its average volume of 6,070,363. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 1.06. The firm has a fifty day simple moving average of $17.70 and a two-hundred day simple moving average of $18.28. Healthpeak Properties, Inc. has a fifty-two week low of $16.63 and a fifty-two week high of $23.26. The stock has a market cap of $12.42 billion, a price-to-earnings ratio of 74.48, a P/E/G ratio of 2.30 and a beta of 1.07.
Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting the consensus estimate of $0.46. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. The business had revenue of $694.35 million for the quarter, compared to analyst estimates of $697.14 million. During the same period in the previous year, the business earned $0.45 EPS. The firm's revenue was down .2% on a year-over-year basis. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. Equities analysts forecast that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.
Healthpeak Properties Announces Dividend
The company also recently declared a monthly dividend, which was paid on Friday, August 29th. Investors of record on Monday, August 18th were issued a dividend of $0.1017 per share. This represents a c) annualized dividend and a yield of 6.8%. The ex-dividend date of this dividend was Monday, August 18th. Healthpeak Properties's dividend payout ratio (DPR) is currently 508.33%.
Insider Activity
In related news, CEO Scott M. Brinker bought 2,930 shares of Healthpeak Properties stock in a transaction dated Thursday, July 31st. The shares were bought at an average cost of $17.06 per share, for a total transaction of $49,985.80. Following the completion of the transaction, the chief executive officer owned 210,416 shares of the company's stock, valued at approximately $3,589,696.96. This trade represents a 1.41% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders have purchased 8,783 shares of company stock worth $150,129 in the last quarter. 0.23% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
A number of research analysts recently commented on DOC shares. Wells Fargo & Company dropped their price target on Healthpeak Properties from $20.00 to $18.00 and set an "equal weight" rating for the company in a research note on Wednesday, August 27th. Morgan Stanley reduced their price target on Healthpeak Properties from $22.00 to $21.00 and set an "overweight" rating on the stock in a report on Friday, August 22nd. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating and issued a $18.00 target price (down from $28.00) on shares of Healthpeak Properties in a report on Wednesday, August 20th. Robert W. Baird set a $21.00 price target on Healthpeak Properties and gave the company an "outperform" rating in a research note on Wednesday, July 30th. Finally, Wall Street Zen lowered Healthpeak Properties from a "hold" rating to a "sell" rating in a research report on Monday, July 7th. Seven equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, Healthpeak Properties has an average rating of "Moderate Buy" and a consensus price target of $21.50.
Read Our Latest Research Report on Healthpeak Properties
Healthpeak Properties Company Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Articles

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.